Related Experiment Videos

Complications of growth hormone therapy in children

S L Blethen1

  • 1Department of Pediatrics, State University of New York at Stony Brook 11794-8111, USA.

Insights

Recombinant human growth hormone (GH) therapy is increasingly used, prompting safety reviews. Current evidence suggests GH treatment is safe, but long-term patient monitoring remains essential.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Pediatrics

Background:

  • Recombinant DNA technology has increased access to human growth hormone (GH) for therapeutic use.
  • Expanded indications for GH treatment raise questions about its safety profile beyond GH deficiency.

Purpose of the Study:

  • To review the safety of human growth hormone (GH) therapy.
  • To evaluate the effects of GH on various physiological systems and potential risks.

Main Methods:

  • Literature review of studies on GH effects.
  • Analysis of safety data concerning metabolism, intracranial pressure, skeletal changes, malignancy, and immune function.

Main Results:

  • GH influences fluid, lipid, and carbohydrate metabolism.
  • No definitive increased risk of intracranial hypertension, malignancy, or adverse immune effects observed.
  • Skeletal effects require ongoing evaluation.

Conclusions:

  • Current data indicate that human growth hormone (GH) treatment is generally safe.
  • Long-term follow-up studies are crucial for comprehensive safety assessment in treated patients.

Related Concept Videos